MMedication Read More FDA Approves Omeros’ YARTEMLEA® – First and Only Therapy Indicated for TA-TMADecember 24, 2025 Approval of YARTEMLEA was based on results from a single-arm, open-label study in adults with TA-TMA (the TA-TMA…
MMedication Read More FDA voucher program has led to political interference in drug reviews, staffers sayDecember 19, 2025 WASHINGTON — A new program intended to fast-track drug reviews at the Food and Drug Administration is quickly…
MMedication Read More Female libido pill gets expanded approval for menopause by FDADecember 17, 2025 U.S. health officials have expanded approval of a much-debated drug aimed at boosting female libido, saying the once-a-day pill can now…
MMedication Read More Will FDA Approval of an In‑House Teriparatide Pen Reshape Amphastar Pharmaceuticals’ (AMPH) Narrative?December 17, 2025 In December 2025, Amphastar Pharmaceuticals announced that the FDA approved its abbreviated new drug application for a teriparatide…
MMedication Read More Amphastar Announces FDA Approval for Teriparatide InjectionDecember 15, 2025 RANCHO CUCAMONGA, CA / ACCESS Newswire / December 15, 2025 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced that the…
HHealth Read More Childhood Vaccine Upheaval Won’t Stop With Changes In Hep B GuidanceDecember 8, 2025 Dr. Retsef Levi speaks during a meeting of the Advisory Committee in Immunization Practices. ACIP is changing its…
MMedication Read More Regulatory reform can unlock access to biosimilarsDecember 5, 2025 Every day, I think about the patients waiting for medicines that could change, or even save, their lives.…
HHealthcare Read More Otsuka’s kidney therapy gets accelerated FDA approvalDecember 2, 2025 Voyxact gets accelerated approval, offering investors a new entrant in the high-value kidney disease market. The Food and…
HHealthcare Read More FDA offers staff “agentic AI” to support pre-market reviews, other tasksDecember 2, 2025 Mario Aguilar covers technology in health care, including artificial intelligence, virtual reality, wearable devices, telehealth, and digital therapeutics.…
HHealth Read More MannKind Announces U.S. FDA Accepts for Review itsDecember 1, 2025 If approved, ReadyFlow Autoinjector would deliver an IV-equivalent diuretic dose (subcutaneous furosemide injection 80 mg/ml) in under 10…
MMedication Read More Walgreens recalls nasal spray over possible contaminationNovember 28, 2025 (CNN) – Walgreens is recalling more than 41,000 bottles of nasal spray because they may be contaminated with…
HHealthcare Read More Novo Nordisk files for FDA approval of a higher dose of Wegovy® injection 7.2 mgNovember 26, 2025 If approved, investigational semaglutide 7.2 mg injection would offer the optionality of a higher dose for greater weight…